The SIRveNIB and SARAH trials, radioembolization vs . sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future

The SIRveNIB and SARAH trials, radioembolization vs . sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hepatobiliary surgery and nutrition 2018-12, Vol.7 (6), p.487-489
Hauptverfasser: Sposito, Carlo, Mazzaferro, Vincenzo
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 489
container_issue 6
container_start_page 487
container_title Hepatobiliary surgery and nutrition
container_volume 7
creator Sposito, Carlo
Mazzaferro, Vincenzo
description
doi_str_mv 10.21037/hbsn.2018.10.06
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6295389</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>30652096</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-a14f9e16f61996bc382cdf6583c76c82ffcc540dd960c3d23821d064ae77fa13</originalsourceid><addsrcrecordid>eNpVUU1PAjEQbYxGCHL3ZPoDANvtbnfrwQSJCgnRBDh423T7IU2g3bTLJvor_MkWUKKnmcyb995kHgDXGI0SjEh-u66CHSUIF6M4QvQMdBOC0iEp2Nv5qS9wB_RDMBUiLGMIFewSdAiiWYIY7YKv1VrB5WzRqpfZA-RWwuV4MZ7Cxhu-CQPouTRObSu3MZ-8Mc7CNsARDM5zraypoLGQy5ZboSScTiawjlvKNuEOesWDswFq5yGHmpvNzqvBwaNWPtRKNKZVR7yJV-hdExeuwIWOzqr_U3tg9fS4mkyH89fn2WQ8HwqS0WbIcaqZwlRTzBitBCkSITXNCiJyKopEayGyFEnJKBJEJhHHEtGUqzzXHJMeuD_K1rtqq6SIJ3u-KWtvttx_lI6b8j9izbp8d21JE5bFD0cBdBQQ3oXglT5xMSoP-ZT7fMp9PvsRopFy89fzRPhNg3wDW9aPBA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The SIRveNIB and SARAH trials, radioembolization vs . sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Sposito, Carlo ; Mazzaferro, Vincenzo</creator><creatorcontrib>Sposito, Carlo ; Mazzaferro, Vincenzo</creatorcontrib><identifier>ISSN: 2304-3881</identifier><identifier>EISSN: 2304-389X</identifier><identifier>DOI: 10.21037/hbsn.2018.10.06</identifier><identifier>PMID: 30652096</identifier><language>eng</language><publisher>China (Republic : 1949- ): AME Publishing Company</publisher><ispartof>Hepatobiliary surgery and nutrition, 2018-12, Vol.7 (6), p.487-489</ispartof><rights>2018 Hepatobiliary Surgery and Nutrition. All rights reserved. 2018 Hepatobiliary Surgery and Nutrition.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-a14f9e16f61996bc382cdf6583c76c82ffcc540dd960c3d23821d064ae77fa13</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295389/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295389/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30652096$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sposito, Carlo</creatorcontrib><creatorcontrib>Mazzaferro, Vincenzo</creatorcontrib><title>The SIRveNIB and SARAH trials, radioembolization vs . sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future</title><title>Hepatobiliary surgery and nutrition</title><addtitle>Hepatobiliary Surg Nutr</addtitle><issn>2304-3881</issn><issn>2304-389X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpVUU1PAjEQbYxGCHL3ZPoDANvtbnfrwQSJCgnRBDh423T7IU2g3bTLJvor_MkWUKKnmcyb995kHgDXGI0SjEh-u66CHSUIF6M4QvQMdBOC0iEp2Nv5qS9wB_RDMBUiLGMIFewSdAiiWYIY7YKv1VrB5WzRqpfZA-RWwuV4MZ7Cxhu-CQPouTRObSu3MZ-8Mc7CNsARDM5zraypoLGQy5ZboSScTiawjlvKNuEOesWDswFq5yGHmpvNzqvBwaNWPtRKNKZVR7yJV-hdExeuwIWOzqr_U3tg9fS4mkyH89fn2WQ8HwqS0WbIcaqZwlRTzBitBCkSITXNCiJyKopEayGyFEnJKBJEJhHHEtGUqzzXHJMeuD_K1rtqq6SIJ3u-KWtvttx_lI6b8j9izbp8d21JE5bFD0cBdBQQ3oXglT5xMSoP-ZT7fMp9PvsRopFy89fzRPhNg3wDW9aPBA</recordid><startdate>20181201</startdate><enddate>20181201</enddate><creator>Sposito, Carlo</creator><creator>Mazzaferro, Vincenzo</creator><general>AME Publishing Company</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20181201</creationdate><title>The SIRveNIB and SARAH trials, radioembolization vs . sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future</title><author>Sposito, Carlo ; Mazzaferro, Vincenzo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-a14f9e16f61996bc382cdf6583c76c82ffcc540dd960c3d23821d064ae77fa13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Sposito, Carlo</creatorcontrib><creatorcontrib>Mazzaferro, Vincenzo</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Hepatobiliary surgery and nutrition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sposito, Carlo</au><au>Mazzaferro, Vincenzo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The SIRveNIB and SARAH trials, radioembolization vs . sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future</atitle><jtitle>Hepatobiliary surgery and nutrition</jtitle><addtitle>Hepatobiliary Surg Nutr</addtitle><date>2018-12-01</date><risdate>2018</risdate><volume>7</volume><issue>6</issue><spage>487</spage><epage>489</epage><pages>487-489</pages><issn>2304-3881</issn><eissn>2304-389X</eissn><cop>China (Republic : 1949- )</cop><pub>AME Publishing Company</pub><pmid>30652096</pmid><doi>10.21037/hbsn.2018.10.06</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2304-3881
ispartof Hepatobiliary surgery and nutrition, 2018-12, Vol.7 (6), p.487-489
issn 2304-3881
2304-389X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6295389
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
title The SIRveNIB and SARAH trials, radioembolization vs . sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T05%3A14%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20SIRveNIB%20and%20SARAH%20trials,%20radioembolization%20vs%20.%20sorafenib%20in%20advanced%20HCC%20patients:%20reasons%20for%20a%20failure,%20and%20perspectives%20for%20the%20future&rft.jtitle=Hepatobiliary%20surgery%20and%20nutrition&rft.au=Sposito,%20Carlo&rft.date=2018-12-01&rft.volume=7&rft.issue=6&rft.spage=487&rft.epage=489&rft.pages=487-489&rft.issn=2304-3881&rft.eissn=2304-389X&rft_id=info:doi/10.21037/hbsn.2018.10.06&rft_dat=%3Cpubmed_cross%3E30652096%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/30652096&rfr_iscdi=true